Mainz Biomed N.V. (BST: 4TO)
Germany
· Delayed Price · Currency is EUR
0.209
-0.024 (-10.13%)
At close: Nov 18, 2024
Mainz Biomed Revenue
Mainz Biomed had revenue of $260.39K USD in the quarter ending June 30, 2024, with 4.60% growth. This brings the company's revenue in the last twelve months to $917.20K, up 16.23% year-over-year. In the year 2023, Mainz Biomed had annual revenue of $895.48K with 69.00% growth.
Revenue (ttm)
$917.20K
Revenue Growth
+16.23%
P/S Ratio
n/a
Revenue / Employee
$12.92K
Employees
71
Market Cap
5.45M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 895.48K | 365.60K | 69.00% |
Dec 31, 2022 | 529.88K | -47.47K | -8.22% |
Dec 31, 2021 | 577.35K | 83.78K | 16.98% |
Dec 31, 2020 | 493.57K | 212.17K | 75.40% |
Dec 31, 2019 | 281.39K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMainz Biomed News
- 4 weeks ago - EQS-News: Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update - Wallstreet:Online
- 4 weeks ago - Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version - GlobeNewsWire
- 7 weeks ago - EQS-News: Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025 - Wallstreet:Online
- 7 weeks ago - Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025 - GlobeNewsWire
- 2 months ago - EQS-News: Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador - Wallstreet:Online
- 2 months ago - Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador - GlobeNewsWire
- 2 months ago - EQS-News: Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert - Wallstreet:Online